Clinical trial
Vision II: Non Randomized French Evaluation of GALILEO Intravascular Radiotherapy System in Patients With de Novo Coronary Arteries Lesions by Restenosis on Angioplasty or Restenosis on Endoprosthesis
NCT00180583 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Vision II: Non Randomized French Evaluation of GALILEO Intravascular Radiotherapy System in Patients With de Novo Coronary Arteries Lesions by Restenosis on Angioplasty or Restenosis on Endoprosthesis
- Lead sponsor
- Abbott Medical Devices
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 28, 2002
- Completion date
- July 31, 2005
- Enrollment
- 268 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.